Condition: Parkinson Disease · Dystonia · Essential Tremor · Sponsor: Boston Scientific Corporation
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
This description comes directly from the study's public registry record.
Stephanie Delvaux · 855-213-9890 · BSNClinicalTrials@bsci.com
Diane Keesey · 855-213-9890 · BSNClinicalTrials@bsci.com
Always discuss trial participation with your own doctor first.
| Uniklinik Köln | Cologne, Germany | Recruiting |
| Universitaetsklinikum Dusseldorf | Düsseldorf, Germany | Recruiting |
| Universitaetsklinikum Wuerzburg | Würzburg, Germany | Recruiting |
| St. Georges Hospital | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06553625